FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2521806208> ?p ?o ?g. }

• W2521806208 endingPage "126" @default.
• W2521806208 startingPage "113" @default.
• W2521806208 abstract "The role of oxidized lipoproteins (high-density [HDLox] and low-density [LDLox]) and total lipoprotein particle (Lp) number and size in HIV-related cardiovascular disease (CVD) is unclear. The goal of this study was to evaluate changes of these biomarkers and their associations with rate of carotid intima media thickness progression over 3 years (ΔCIMT) in chronic HIV infection.Prospective study of 234 HIV-infected antiretroviral treatment-naive participants without CVD who were randomized to receive tenofovir-emtricitabine plus atazanavir/ritonavir, darunavir/ritonavir or raltegravir (RAL) and achieved plasma HIV-1 RNA <50 copies/ml by week 24 and thereafter. Biomarker changes over 24, 48 or 96 weeks from baseline and pairwise treatment group comparisons were examined. Associations of these biomarkers with ΔCIMT were analysed with mixed effects linear regression.HDLp number increased with both protease inhibitors (PIs) over 48 weeks, while LDLp number declined with RAL; Lp size did not change. Over 96 weeks, normalized HDLox declined with both PIs; LDLox increased in all groups. Few treatment group differences were observed across all biomarkers. Associations between ΔCIMT and oxidized lipoproteins at all time points were not apparent (P≥0.10). There was some evidence of slower ΔCIMT for higher HDLp number (P=0.06) and for lower LDLp number (P=0.08) measured at baseline.Unexpectedly, LDLox increased modestly in all treatment groups after ART initiation. Associations of plasma HDLox and LDLox with ΔCIMT were not apparent. While plasma levels of abnormal lipoproteins have been shown to be associated with CVD outcomes, clear associations with sub-clinical atherosclerosis progression were not apparent in our study." @default.
• W2521806208 created "2016-09-30" @default.
• W2521806208 creator A5000167800 @default.
• W2521806208 creator A5008957693 @default.
• W2521806208 creator A5027304381 @default.
• W2521806208 creator A5031150721 @default.
• W2521806208 creator A5049227770 @default.
• W2521806208 creator A5055013057 @default.
• W2521806208 creator A5062526829 @default.
• W2521806208 creator A5064935269 @default.
• W2521806208 creator A5084353681 @default.
• W2521806208 creator A5085723076 @default.
• W2521806208 date "2016-02-01" @default.
• W2521806208 modified "2023-10-18" @default.
• W2521806208 title "Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s" @default.
• W2521806208 cites W128919346 @default.
• W2521806208 cites W1925545124 @default.
• W2521806208 cites W1965977455 @default.
• W2521806208 cites W1967469251 @default.
• W2521806208 cites W1972506621 @default.
• W2521806208 cites W1980232183 @default.
• W2521806208 cites W2001231188 @default.
• W2521806208 cites W2002053621 @default.
• W2521806208 cites W2005230846 @default.
• W2521806208 cites W2016645249 @default.
• W2521806208 cites W2029148240 @default.
• W2521806208 cites W2030535590 @default.
• W2521806208 cites W2040429239 @default.
• W2521806208 cites W2044495091 @default.
• W2521806208 cites W2045619313 @default.
• W2521806208 cites W2046351301 @default.
• W2521806208 cites W2047220571 @default.
• W2521806208 cites W2047542844 @default.
• W2521806208 cites W2049102297 @default.
• W2521806208 cites W2055111878 @default.
• W2521806208 cites W2055823448 @default.
• W2521806208 cites W2059416535 @default.
• W2521806208 cites W2061685109 @default.
• W2521806208 cites W2063116304 @default.
• W2521806208 cites W2067036095 @default.
• W2521806208 cites W2075388292 @default.
• W2521806208 cites W2088643134 @default.
• W2521806208 cites W2090055160 @default.
• W2521806208 cites W2092831846 @default.
• W2521806208 cites W2098080433 @default.
• W2521806208 cites W2105537689 @default.
• W2521806208 cites W2106227625 @default.
• W2521806208 cites W2108676219 @default.
• W2521806208 cites W2111362720 @default.
• W2521806208 cites W2131142211 @default.
• W2521806208 cites W2136949091 @default.
• W2521806208 cites W2142008513 @default.
• W2521806208 cites W2143062755 @default.
• W2521806208 cites W2143576216 @default.
• W2521806208 cites W2150750362 @default.
• W2521806208 cites W2155208388 @default.
• W2521806208 cites W2157969042 @default.
• W2521806208 cites W2162440708 @default.
• W2521806208 cites W2163289904 @default.
• W2521806208 cites W2168175864 @default.
• W2521806208 cites W2169264636 @default.
• W2521806208 cites W2402331083 @default.
• W2521806208 cites W2415979752 @default.
• W2521806208 cites W2434245634 @default.
• W2521806208 cites W2528387992 @default.
• W2521806208 doi "https://doi.org/10.3851/imp3093" @default.
• W2521806208 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5364070" @default.
• W2521806208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27661466" @default.
• W2521806208 hasPublicationYear "2016" @default.
• W2521806208 type Work @default.
• W2521806208 sameAs 2521806208 @default.
• W2521806208 citedByCount "11" @default.
• W2521806208 countsByYear W25218062082017 @default.
• W2521806208 countsByYear W25218062082018 @default.
• W2521806208 countsByYear W25218062082019 @default.
• W2521806208 countsByYear W25218062082020 @default.
• W2521806208 countsByYear W25218062082021 @default.
• W2521806208 countsByYear W25218062082022 @default.
• W2521806208 crossrefType "journal-article" @default.
• W2521806208 hasAuthorship W2521806208A5000167800 @default.
• W2521806208 hasAuthorship W2521806208A5008957693 @default.
• W2521806208 hasAuthorship W2521806208A5027304381 @default.
• W2521806208 hasAuthorship W2521806208A5031150721 @default.
• W2521806208 hasAuthorship W2521806208A5049227770 @default.
• W2521806208 hasAuthorship W2521806208A5055013057 @default.
• W2521806208 hasAuthorship W2521806208A5062526829 @default.
• W2521806208 hasAuthorship W2521806208A5064935269 @default.
• W2521806208 hasAuthorship W2521806208A5084353681 @default.
• W2521806208 hasAuthorship W2521806208A5085723076 @default.
• W2521806208 hasBestOaLocation W25218062082 @default.
• W2521806208 hasConcept C126322002 @default.
• W2521806208 hasConcept C134018914 @default.
• W2521806208 hasConcept C142462285 @default.
• W2521806208 hasConcept C164705383 @default.
• W2521806208 hasConcept C185592680 @default.
• W2521806208 hasConcept C203014093 @default.
• W2521806208 hasConcept C2777182164 @default.
• W2521806208 hasConcept C2778163477 @default.

• next